Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Effect of anti-CD25 antibody daclizumab in the inhibition of inflammation and stabilization of disease progression in multiple sclerosis.
Berlex continues legal challenge to FDA over MS drug.
Nephrotic-range proteinuria on interferon-β treatment: immune-induced glomerulonephritis or other pathway?
Regulation of prefrontal cortex myelination by the microbiota.
IL-17 and GM-CSF Expression Are Antagonistically Regulated by Human T Helper Cells.
Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan.
Neuronal expression of pathological tau accelerates oligodendrocyte progenitor cell differentiation.
Translating state-of-the-art spinal cord MRI techniques to clinical use: A systematic review of clinical studies utilizing DTI, MT, MWF, MRS, and fMRI.
Limit cycle oscillations in standing human posture.
The effects of teriflunomide on lymphocyte subpopulations in human peripheral blood mononuclear cells in vitro.
Randomized controlled trial of interferon- beta-1a in secondary progressive MS: Clinical results.
A double-blind clinical trial of mitoxantrone versus methylprednisolone in relapsing, secondary progressive multiple sclerosis.
NOVANTRONE. mitoXANTRONE for injection concentrate
Molecular characterization of a peripheral receptor for cannabinoids.
Effector T-cell trafficking between the leptomeninges and the cerebrospinal fluid.
Interferon-β-1b: a review of its use in multiple sclerosis.
Glatiramer acetate (GA) prevents TNF-α-induced monocyte adhesion to primary endothelial cells through interfering with the NF-κB pathway.
Receptos to initiate Phase 3 trial of RPC1063 in relapsing multiple sclerosis
Flupirtine shows functional NMDA receptor antagonism by enhancing Mg2+ block via activation of voltage independent potassium channels. Rapid communication.
Flupirtine
PLEGRIDY® (Peginterferon Beta-1a) Three-Year Data Presented at AAN Annual Meeting Support Long-Term Safety and Efficacy in Multiple Sclerosis Patients
Evaluation of circulating osteopontin levels in an unselected cohort of patients with multiple sclerosis: relevance for biomarker development.
Association of Vitamin D Levels With Multiple Sclerosis Activity and Progression in Patients Receiving Interferon Beta-1b.
CCR2 defines in vivo development and homing of IL-23-driven GM-CSF-producing Th17 cells.
Secondary Progression in Multiple Sclerosis: Neuronal Exhaustion or Distinct Pathology?

Pages